Podocyte NLRP3 Inflammasome Activation and Formation by Adipokine Visfatin

Podocyte NLRP3 Inflammasome Activation and Formation by Adipokine Visfatin

Bibliographic Details
Main Authors:	Saisudha Koka, Min Xia, Chun Zhang, Yang Zhang, Pin-Lan Li, Krishna M. Boini
Format:	Article
Language:	English
Published:	Cell Physiol Biochem Press GmbH & Co KG 2019-08-01
Series:	Cellular Physiology and Biochemistry
Online Access:	https://www.cellphysiolbiochem.com/Articles/000143/

Similar Items

Endothelial NLRP3 inflammasome activation and arterial neointima formation associated with acid sphingomyelinase during hypercholesterolemia
by: Saisudha Koka, et al.
Published: (2017-10-01)

Characterization and Activation of NLRP3 Inflammasomes in the Renal Medulla in Mice
by: Min Xia, et al.
Published: (2016-03-01)

Trimethylamine-N-Oxide Instigates NLRP3 Inflammasome Activation and Endothelial Dysfunction
by: Krishna M. Boini, et al.
Published: (2017-11-01)

Activation of Nlrp3 inflammasomes enhances macrophage lipid-deposition and migration: implication of a novel role of inflammasome in atherogenesis.
by: Xiang Li, et al.
Published: (2014-01-01)

Inhibition of Hyperhomocysteinemia-Induced Inflammasome Activation and Glomerular Sclerosis by NLRP3 Gene Deletion
by: Min Xia, et al.
Published: (2014-08-01)

Redox Triggering of Podocyte NLRP3 Inflammasomes and Glomerular Injury in Hyperhomocysteinemia
by: Abais, Justine M.
Published: (2014)

D-Ribose Induces Podocyte NLRP3 Inflammasome Activation and Glomerular Injury via AGEs/RAGE Pathway
by: Jinni Hong, et al.
Published: (2019-10-01)

Visfatin/Nampt: An Adipokine with Cardiovascular Impact
by: Tania Romacho, et al.
Published: (2013-01-01)

SIRT1 Alleviates Aldosterone-Induced Podocyte Injury by Suppressing Mitochondrial Dysfunction and NLRP3 Inflammasome Activation
by: Mingzhu Jiang, et al.
Published: (2021-03-01)

CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy
by: Jing Zhao, et al.
Published: (2019-01-01)

Cathepsin B-Mediated NLRP3 Inflammasome Formation and Activation in Angiotensin II -Induced Hypertensive Mice: Role of Macrophage Digestion Dysfunction
by: Dawei Lian, et al.
Published: (2018-10-01)

Evaluation of Adipokines: Apelin, Visfatin, and Resistin in Children with Atopic Dermatitis
by: Edyta Machura, et al.
Published: (2013-01-01)

Corrigendum to “CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy”
by: Jing Zhao, et al.
Published: (2019-01-01)

High Mobility Group Box 1 Mediates TMAO-Induced Endothelial Dysfunction
by: Gurinder Bir Singh, et al.
Published: (2019-07-01)

NLRP3 Inflammasome and Inflammatory Diseases
by: Zheng Wang, et al.
Published: (2020-01-01)

Role of the NLRP3 Inflammasome: Insights Into Cancer Hallmarks
by: Ting-Yi Lin, et al.
Published: (2021-02-01)

RACK1 Mediates NLRP3 Inflammasome Activation by Promoting NLRP3 Active Conformation and Inflammasome Assembly
by: Yanhui Duan, et al.
Published: (2020-11-01)

Inhibiting the NLRP3 Inflammasome
by: Lina Y. El-Sharkawy, et al.
Published: (2020-11-01)

NLRP3 Inflammasome and Inflammatory Bowel Disease
by: Yu Zhen, et al.
Published: (2019-02-01)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
by: Yang Gyun Kim, et al.
Published: (2019-11-01)

Obesity: An overview on its current perspectives and treatment options
by: Chinnala Krishna M, et al.
Published: (2004-04-01)

NLRP3 Inflammasome in Metabolic-Associated Kidney Diseases: An Update
by: Wei Xiong, et al.
Published: (2021-07-01)

Activation of NLRP3 Inflammasome and Onset of Alzheimer’s Disease
by: Hua Bai, et al.
Published: (2021-07-01)

Vitamin D and the NLRP3 Inflammasome
by: Matthew Tunbridge, et al.
Published: (2020-11-01)

Role of the NLRP3 Inflammasome in Preeclampsia
by: Koumei Shirasuna, et al.
Published: (2020-02-01)

Regulation of NLRP3 Inflammasome by Phosphorylation
by: Nan Song, et al.
Published: (2018-10-01)

Role of the NLRP3 inflammasome in cancer
by: Maryam Moossavi, et al.
Published: (2018-11-01)

Pharmacological Inhibitors of the NLRP3 Inflammasome
by: Ayesha Zahid, et al.
Published: (2019-10-01)

Spotlight on the NLRP3 inflammasome pathway
by: Groslambert M, et al.
Published: (2018-09-01)

The role of the NLRP3 inflammasome in gout
by: Sarah R Kingsbury, et al.
Published: (2011-03-01)

NLRP3 Inflammasome and Pathobiology in AMD
by: Lucia Celkova, et al.
Published: (2015-01-01)

NLRP3 Inflammasome and MS/EAE
by: Makoto Inoue, et al.
Published: (2013-01-01)

Targeting the NLRP3 Inflammasome in Glaucoma
by: Sophie Coyle, et al.
Published: (2021-08-01)

Neurodegenerative Disease and the NLRP3 Inflammasome
by: Jonathan A. Holbrook, et al.
Published: (2021-03-01)

Assessment of Salivary Adipokines Resistin, Visfatin, and Ghrelin as Type 2 Diabetes Mellitus Biomarkers
by: Mythily Srinivasan, et al.
Published: (2018-01-01)

Activation of Platelet NLRP3 Inflammasome in Crohn’s Disease
by: Ge Zhang, et al.
Published: (2021-06-01)

NLRP3 Inflammasome Formation and Activation in Nonalcoholic Steatohepatitis: Therapeutic Target for Antimetabolic Syndrome Remedy FTZ
by: Yu Chen, et al.
Published: (2018-01-01)

Artificially Cultivated Ophiocordyceps sinensis Alleviates Diabetic Nephropathy and Its Podocyte Injury via Inhibiting P2X7R Expression and NLRP3 Inflammasome Activation
by: Chao Wang, et al.
Published: (2018-01-01)

The NLRP3 Inflammasome and Its Role in T1DM
by: Xiaoxiao Sun, et al.
Published: (2020-08-01)

Inflammasome : Investigating the effect of NEK7 in the activation of the NLRP3 Inflammasome
by: Adindu Uzowuru, Cosmas
Published: (2020)